Detalhe da pesquisa
1.
Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.
Int J Mol Sci
; 22(22)2021 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830435
2.
Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Disease.
Cell J
; 24(7): 353-363, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043403
3.
47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study).
Eurasian J Med
; 54(3): 310-312, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950831
4.
The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies.
Int Immunopharmacol
; 95: 107565, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773205
5.
Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders.
Iran J Allergy Asthma Immunol
; 19(3): 209-228, 2020 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615656